Our data is also lower than another study of Beth Israel Deaconess Medical Center, Harvard Medical School) which showed 29.6% of adenocarcinoma had a PD‐L1 TPS of at least 50%.27 The gene discussed is CD274; the disease is adenocarcinoma.